Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
86 hedge funds and large institutions have $32.3M invested in Spectrum Pharmaceuticals Inc in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 31 closing their positions.
1,271% more call options, than puts
Call options by funds: $480K | Put options by funds: $35K
15% less funds holding
Funds holding: 101 → 86 (-15)
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
42% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 31
65% less capital invested
Capital invested by funds: $92.5M → $32.3M (-$60.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$762K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$653K |
| 4 |
E
Ergoteles
New York
|
+$392K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$343K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$6.97M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.31M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.09M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.01M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$874K |
SPPI Hedge Fund Activity: Q2 2022 in Review
86 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2022, worth a combined $32.3M — down 65% from $92.5M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of SPPI and 18 opened new positions — a net loss of 13 holders — while 25 trimmed existing stakes and 20 added.
The largest buyer was Millennium Management, adding an estimated $1.7M. The largest seller was BlackRock, cutting an estimated $6.97M.
- 86 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2022, down from 101 in Q1 2022.
- Funds reported $32.3M of Spectrum Pharmaceuticals Inc stock for Q2 2022, down 65% quarter-over-quarter.
- 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2022 and 31 closed out, a net change of -13 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2022 was Millennium Management, an estimated $1.7M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2022 was BlackRock, an estimated $6.97M sold.
Based on aggregated 13F filings for Q2 2022.